XENOBREAST Trial: A prospective study of xenografts establishment from surgical specimens of patients with triple negative or luminal b breast cancer

Introduction: Patient-derived xenografts (PDX) can be used to explore tumour pathophysiology and could be useful to better understand therapeutic response in breast cancer. PDX from mammary tumours are usually made from metastatic tumours. Thus, PDX from primary mammary tumours or after neoadjuvant...

Descripción completa

Detalles Bibliográficos
Autores principales: Veyssière, Hugo, Passildas, Judith, Ginzac, Angeline, Lusho, Sejdi, Bidet, Yannick, Molnar, Ioana, Bernadach, Maureen, Cavaille, Mathias, Radosevic-Robin, Nina, Durando, Xavier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258709/
https://www.ncbi.nlm.nih.gov/pubmed/34249349
http://dx.doi.org/10.12688/f1000research.26873.3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258709/
https://www.ncbi.nlm.nih.gov/pubmed/34249349
http://dx.doi.org/10.12688/f1000research.26873.3

Ejemplares similares